591 related articles for article (PubMed ID: 22271002)
1. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.
Maes M; Fišar Z; Medina M; Scapagnini G; Nowak G; Berk M
Inflammopharmacology; 2012 Jun; 20(3):127-50. PubMed ID: 22271002
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.
Leonard B; Maes M
Neurosci Biobehav Rev; 2012 Feb; 36(2):764-85. PubMed ID: 22197082
[TBL] [Abstract][Full Text] [Related]
3. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
Maes M; Galecki P; Chang YS; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):676-92. PubMed ID: 20471444
[TBL] [Abstract][Full Text] [Related]
4. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
[TBL] [Abstract][Full Text] [Related]
5. Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications.
Anderson G; Maes M
Curr Pharm Des; 2014; 20(23):3812-47. PubMed ID: 24180395
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
Morris G; Maes M
Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
[TBL] [Abstract][Full Text] [Related]
7. Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve.
Niringiyumukiza JD; Cai H; Chen L; Li Y; Wang L; Zhang M; Xu X; Xiang W
Biomed Pharmacother; 2019 Aug; 116():108963. PubMed ID: 31125824
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration.
Goodfellow MJ; Borcar A; Proctor JL; Greco T; Rosenthal RE; Fiskum G
Exp Neurol; 2020 Jun; 328():113247. PubMed ID: 32061629
[TBL] [Abstract][Full Text] [Related]
9. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
10. Nrf2: a potential therapeutic target for diabetic neuropathy.
Kumar A; Mittal R
Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
[TBL] [Abstract][Full Text] [Related]
11. Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants.
Lee SY; Lee SJ; Han C; Patkar AA; Masand PS; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():224-35. PubMed ID: 23022673
[TBL] [Abstract][Full Text] [Related]
12. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
Maes M
Neuro Endocrinol Lett; 2008 Jun; 29(3):287-91. PubMed ID: 18580840
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage.
Sotolongo K; Ghiso J; Rostagno A
Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
15. Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction.
Shen T; Li HZ; Li AL; Li YR; Wang XN; Ren DM
Vascul Pharmacol; 2018 Oct; 109():72-82. PubMed ID: 29902531
[TBL] [Abstract][Full Text] [Related]
16. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):784-94. PubMed ID: 20609377
[TBL] [Abstract][Full Text] [Related]
17. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats.
Martín-Hernández D; Bris ÁG; MacDowell KS; García-Bueno B; Madrigal JL; Leza JC; Caso JR
Neuropharmacology; 2016 Apr; 103():79-91. PubMed ID: 26686388
[TBL] [Abstract][Full Text] [Related]
19. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression.
Kubera M; Obuchowicz E; Goehler L; Brzeszcz J; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):744-59. PubMed ID: 20828592
[TBL] [Abstract][Full Text] [Related]
20. Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators.
Gawali NB; Bulani VD; Chowdhury AA; Deshpande PS; Nagmoti DM; Juvekar AR
Pharmacol Biochem Behav; 2016 Oct; 149():1-8. PubMed ID: 27453424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
